You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The labs will provide testing for K-12 schools by testing each consenting person in a classroom as one pool.
Before launching its COVID-19 test, which generated most of Co-Diagnostics' revenues in 2020, the firm's sales primarily came from mosquito-borne virus testing.
For the year ended Dec. 31, 2020, the firm reported revenues of $8.5 million compared to $19.2 million in 2019, beating the Wall Street estimate of $8.3 million.
The agreement is with the Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz.
The company's full-year revenues were $4.2 million, up 20 percent from the year-ago quarter.
Viral entry factors were broadly enriched in the salivary glands and oral mucosae, implicating the oral cavity as an important infection site.
The immune profiling company is looking to expand its functional genomics capabilities to more directly inform immune therapy development and application.
The gut microbiomes of nearly 200 animal species could serve as a resource for the discovery of new therapeutics and biotechnology applications.
The Wall Street Journal reports Moncef Slaoui has been fired from a biotech startup following allegations of sexual harassment.
In a new analysis, AstraZeneca says its SARS-CoV-2 vaccine is 76 percent effective in preventing symptomatic COVID-19, the Associated Press reports.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.